Management change at ALK

Udgivet den 31-07-2017  |  kl. 10:11  |  

Copenhagen, 2017-07-31 10:11 CEST (GLOBE NEWSWIRE) --  

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that Flemming Pedersen, CFO and member of the Board of Management, has decided to resign his position and leave ALK to join a privately owned Danish company in another industry. 

Chairman of the Board of Directors, Steen Riisgaard, and President & CEO, Carsten Hellmann said: We would like to offer our sincere thanks to Flemming for his strong contributions to ALK's development over the past seven years. We will miss him, but respect his decision to move on in his career. 

Flemming Pedersen said: After seven inspiring and successful years with ALK, I have decided to join another company. ALK has become the undisputed leader in allergy immunotherapy and is now pursuing numerous exciting opportunities for further growth. While I am sad to leave ALK and will miss the many outstanding colleagues, partners and investors with whom I have the pleasure to work, I am also looking forward to my new challenge. 

Flemming Pedersen will leave ALK by 31 January 2018 at the latest. A search for a new CFO will now be initiated.
 

ALK-Abelló A/S

 

For further information please contact:
Carsten Hellmann, President & CEO
Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525
Media: Jeppe Ilkjær, tel. +45 7877 4532, mobile +45 3050 2014
 

About ALK
ALK is a research-driven global pharmaceutical company focusing on allergy prevention, diagnosis and treatment. ALK is a world leader in allergy immunotherapy - a treatment of the underlying cause of allergy. The company has approximately 2,300 employees, with subsidiaries, production facilities and distributors worldwide. ALK has entered into partnership agreements with Torii, Abbott, and Seqirus to commercialise sublingual allergy immunotherapy tablets in Japan, Russia, and South-East Asia, and Australia and New Zealand, respectively. The company is headquartered in Hørsholm, Denmark, and listed on Nasdaq Copenhagen. Find more information at www.alk.net.

 

Vedhæftede filer:

FM_19_17UK_31072017.pdf

Udgivet af: NPinvestordk

Mest læste lige nu

Vestas får 50 megawatt-ordre i Sydkorea
Novo Nordisk lancerer Wegovy i Kina
Flere danskere vil bygge sommerhus selv
Tirsdagens danske avisuddrag med Mærsk, Terma og digital valuta
Bavarian Nordic: Farlig variant af mpox konstateret for første gang i USA
 

Seneste nyheder

06:45 Asien: Blandet afslutning på voldsom volatil uge
06:34 DSV's anbefaling hæves til "outperform" og kursmålet løftes 50 pct. hos BNP Paribas
06:34 Carlsbergs anbefaling sænkes til "undervægt" af Barclays
06:34 MT Højgaards kursmål løftes 10 pct. op af SEB
06:34 Ørsteds anbefaling hæves til neutralt niveau hos DNB
06:34 Kinesisk detailsalg overrasker positivt og industriproduktionen viser fortsat gode takter
06:34 Nilfisk dropper vækst og indtjeningsmål efter svært kvartal
06:32 Asien: Blandet afslutning på voldsom volatil uge
06:32 Valuta: Intet tilbagetog eller pusterum for opadgående pres på dollar
06:32 USA/T-bond: Korte renter steg efter Powells kommentarer
06:32 USA/lukning: Tesla tog tungt minus i rødt marked
06:30 Kalender med link - fredag den 15. november
17:51 Noble vil forlade børsen i København og forventer sidste handelsdag i december
17:50 Europa/lukning: Markedet vendte rundt efter besøg i laveste niveau i tre måneder
17:33 Myndigheder skifter mening og anbefaler middel mod Alzheimer - aktie stiger
17:08 Torsdagens aktier: GN og Mærsk holdt sig i toppen mens NKT dykkede
17:02 Torsdagens obligationer: Indledende rentefald gik i sig selv
16:52 Better Collective skærer 300 medarbejdere fra i spareplan
16:07 Amerikansk serverproducent tæt på afgrunden - falder for femte dag i streg
15:40 USA/åbning: Forsigtige smil fra handelsstart og før Powell taler